{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:58:43Z","timestamp":1791118723582,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"QREN","award":["NORTE-07-0124-FEDER-000067-NANOQU\u00cdMICA"],"award-info":[{"award-number":["NORTE-07-0124-FEDER-000067-NANOQU\u00cdMICA"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jconrel.2014.06.020","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T11:02:14Z","timestamp":1403521334000},"page":"169-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Eradication of Helicobacter pylori: Past, present and future"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-6580","authenticated-orcid":false,"given":"Daniela","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-3710","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina L.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.06.020_bb0005","series-title":"Helicobacter pylori","author":"Boyanova","year":"2011"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0010","series-title":"Helicobacter pylori: Physiology and genetics","year":"2001"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2004.06.006","article-title":"Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori","volume":"99","author":"Umamaheshwari","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00066-2","article-title":"A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation","volume":"57","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.279.5349.373","article-title":"Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging","volume":"279","author":"Ilver","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0030","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.90.5.2035","article-title":"An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium","volume":"90","author":"Falk","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0035","series-title":"IARC Working Group on the Evaluation of the Carcinogenic Risks to Humans, Lyon, France","article-title":"A review of human carcinogens. Part B: biological agents","year":"2009"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10096-012-1773-9","article-title":"Is Helicobacter pylori good or bad?","volume":"32","author":"Mishra","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2010.07.014","article-title":"Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma","volume":"305","author":"Kim","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejim.2012.07.006","article-title":"Standard triple and sequential therapies for Helicobacter pylori eradication: an update","volume":"24","author":"Zullo","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656566.2013.763926","article-title":"Current options for the treatment of Helicobacter pylori","volume":"14","author":"Georgopoulos","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.bmb.a011681","article-title":"Helicobacter biology \u2014 discovery","volume":"54","author":"Buckley","year":"1998","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000007461","article-title":"A century of Helicobacter pylori","volume":"59","author":"Kidd","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jamcollsurg.2009.08.014","article-title":"\u201cNo acid, no ulcer\u201d\u2014100years later: a review of the history of peptic ulcer disease","volume":"210","author":"Gustafson","year":"2010","journal-title":"Am. Coll. Surg."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2014.06.020_bb0075","first-page":"23","article-title":"Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer","volume":"54","author":"Konturek","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2014.06.020_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2302\/kjm.51.supplement2_33","article-title":"Gastric spirochaetes: 100years of discovery before and after Kobayashi","volume":"51","author":"Marshall","year":"2002","journal-title":"Keio J. Med."},{"issue":"Suppl. 146","key":"10.1016\/j.jconrel.2014.06.020_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/00365528809099131","article-title":"The Campylobacter pylori story","volume":"23","author":"Marshall","year":"1988","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0090","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.dld.2006.06.013","article-title":"The history of Helicobacter pylori: a reflection on the relationship between the medical community and industry","volume":"38","author":"Ciacci","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0095","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.33073\/pjm-2012-033","article-title":"The controversy over anti-Helicobacter pylori therapy","volume":"61","author":"Bocian","year":"2012","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.28.6.837","article-title":"Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents","volume":"28","author":"McNulty","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.coph.2008.04.010","article-title":"New strategies for Helicobacter pylori eradication","volume":"8","author":"Selgrad","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ejpb.2008.01.018","article-title":"Pre-formulation of liposomes against Helicobacter pylori: characterization and interaction with the bacteria","volume":"69","author":"Bardonnet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/156720107779314811","article-title":"Stomach specific anti-Helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres","volume":"4","author":"Patel","year":"2007","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2036.2001.00923.x","article-title":"The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy","volume":"15","author":"Armuzzi","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0135","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1021\/mp300243w","article-title":"Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori","volume":"9","author":"Obonyo","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/mp8002539","article-title":"Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection","volume":"6","author":"Jain","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0150","first-page":"1","article-title":"Clinical appliance of probiotics in the treatment of Helicobacter pylori infection \u2014 a brief review","author":"Patel","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1574-695X.2011.00865.x","article-title":"Alternative therapies for Helicobacter pylori: probiotics and phytomedicine","volume":"63","author":"V\u00edtor","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.10.031","article-title":"Gastroretentive dosage forms: overview and special case of Helicobacter pylori","volume":"111","author":"Bardonnet","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0165","first-page":"42","article-title":"Focus on current trends in the treatment of Helicobacter pylori infection: an update","volume":"9","author":"Prasanthi","year":"2011","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/viru.2.5.17035","article-title":"The growing role of nanotechnology in combating infectious disease","volume":"2","author":"Blecher","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3797\/scipharm.1011-05","article-title":"Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. pylori","volume":"79","author":"Arora","year":"2011","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tibtech.2012.06.004","article-title":"Antibacterial properties of nanoparticles","volume":"30","author":"Hajipour","year":"2012","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Jung","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0190","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0195","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11095-009-9834-1","article-title":"Selective adhesion of nanoparticles to inflamed tissue in gastric ulcers","volume":"26","author":"Hassani","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(98)00037-4","article-title":"The effect of physical barriers and properties on the oral absorption of particulates","volume":"34","author":"Norris","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0205","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1163\/092050609X12464345137685","article-title":"Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo","volume":"20","author":"Luo","year":"2009","journal-title":"J. Biomater. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0210","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jmmm.2009.02.087","article-title":"Development of a magnetic system for the treatment of Helicobacter pylori infections","volume":"321","author":"Silva","year":"2009","journal-title":"J. Magn. Magn. Mater."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2014.06.020_bb0215","first-page":"171","article-title":"Formulation of clarithromycin loaded mucoadhesive microspheres by emulsification-internal gelation technique for anti-Helicobacter pylori therapy","volume":"3","author":"Sambathkumar","year":"2011","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2013.06.068","article-title":"Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application","volume":"454","author":"Fernandes","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0225","series-title":"Bacterial Pathogenesis: A Molecular Approach","author":"Salyers","year":"2002"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0230","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00102.2004","article-title":"Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin","volume":"288","author":"Allen","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0235","first-page":"268","article-title":"Double liposomes mediated dual drug targeting for treatment of Helicobacter pylori infections","volume":"66","author":"Singh","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.11.033","article-title":"Liposomes as delivery systems for antibiotics","volume":"387","author":"Drulis-Kawa","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2009.03.117","article-title":"Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions","volume":"383","author":"Bardonnet","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/erv.13.20","article-title":"Why can't we make an effective vaccine against Helicobacter pylori?","volume":"12","author":"Sutton","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0255","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1016\/j.vaccine.2007.08.034","article-title":"Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB\/c mice","volume":"25","author":"Zhao","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0260","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.vaccine.2010.12.130","article-title":"HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model","volume":"29","author":"Moss","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0265","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0891-5849(01)00592-5","article-title":"NF-\u03baB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection","volume":"31","author":"Lim","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0270","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08982104.2012.655284","article-title":"Double liposome based dual-drug delivery system as vectors for effective management of peptic ulcer","volume":"22","author":"Jain","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0275","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/S0142-9612(01)00030-8","article-title":"Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake","volume":"22","author":"Fontana","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0280","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0285","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1016208703380","article-title":"In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative","volume":"12","author":"Akiyama","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0939-6411(01)00124-2","article-title":"Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa","volume":"51","author":"Cu\u00f1a","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0295","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.2147\/IJN.S34312","article-title":"Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol(R) nanospheres","volume":"7","author":"Harsha","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","article-title":"Protein-based nanocarriers as promising drug and gene delivery systems","volume":"161","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10611860701733278","article-title":"Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori","volume":"16","author":"Ramteke","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10611860310001647771","article-title":"Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori","volume":"11","author":"Umamaheshwari","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt050232","article-title":"Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model","volume":"5","author":"Umamaheshwari","year":"2004","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0320","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4103\/0250-474X.27822","article-title":"Clarithromycin based oral sustained release nanoparticulate drug delivery system","volume":"68","author":"Ramteke","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0325","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/10611860802295839","article-title":"Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori","volume":"16","author":"Ramteke","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/107175400455173","article-title":"Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori","volume":"7","author":"Wang","year":"2000","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0335","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/DDDT.S39956","article-title":"Pharmaceutical suspension containing both immediate\/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization","volume":"7","author":"Harsha","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0340","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1016\/j.actbio.2013.07.034","article-title":"Bacterial-binding chitosan microspheres for gastric infection treatment and prevention","volume":"9","author":"Goncalves","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0345","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(01)00985-1","article-title":"Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracyline-loaded chitosan microspheres","volume":"235","author":"Hejazi","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0350","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1016\/j.actbio.2012.09.011","article-title":"Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer","volume":"9","author":"Nogueira","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0355","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.biomaterials.2013.02.028","article-title":"Genipin-cross-linked fucose-chitosan\/heparin nanoparticles for the eradication of Helicobacter pylori","volume":"34","author":"Lin","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0360","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.fct.2009.01.037","article-title":"Gardenia jasminoides Ellis ethanol extract and its constituents reduce the risks of gastritis and reverse gastric lesions in rats","volume":"47","author":"Lee","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0365","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1211\/0022357991772952","article-title":"Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection","volume":"51","author":"Shah","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0370","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/0265204021000022761","article-title":"Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa","volume":"19","author":"Portero","year":"2002","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0375","first-page":"69","article-title":"Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity","volume":"10","author":"Remu\u00f1\u00e1n-L\u00f3pez","year":"2000","journal-title":"STP Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0380","first-page":"455","article-title":"Formulation and in vitro characterization of spray dried microspheres of amoxicillin","volume":"60","author":"Raval","year":"2010","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0385","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/02652048.2012.655329","article-title":"Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO2","volume":"29","author":"Patel","year":"2012","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0390","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1081\/PDT-120022154","article-title":"Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils","volume":"8","author":"Hejazi","year":"2003","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2003.12.001","article-title":"Stomach-specific anti-H. pylori therapy Part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils","volume":"272","author":"Hejazi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10570-006-9070-3","article-title":"Tetracycline-containing chitosan microspheres for local treatment of Helicobacter pylori infection","volume":"14","author":"Amiji","year":"2006","journal-title":"Cellulose"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: properties and biomedical applications","volume":"37","author":"Lee","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0410","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2004.05.009","article-title":"Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties","volume":"98","author":"Leonard","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(03)00159-5","article-title":"In vitro and in vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate","volume":"258","author":"Miyazaki","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0420","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.biomaterials.2009.02.036","article-title":"Development of pH-responsive chitosan\/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy","volume":"30","author":"Lin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0425","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1128\/AAC.42.10.2492","article-title":"Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori","volume":"42","author":"Nagahara","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/713840399","article-title":"A new approach in gastroretentive drug delivery system using cholestyramine","volume":"10","author":"Umamaheshwari","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0435","first-page":"172","article-title":"Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori","volume":"297","author":"Chun","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2004.06.022","article-title":"In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin","volume":"102","author":"Liu","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0445","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1248\/cpb.56.1658","article-title":"Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori","volume":"56","author":"Rajinikanth","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0450","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/02652040802373012","article-title":"Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy","volume":"26","author":"Patel","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0455","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/mp800193n","article-title":"Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori","volume":"6","author":"Jain","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0460","first-page":"267","article-title":"Lectin conjugated gastro-retentive microspheres of amoxicillin for effective treatment of Helicobacter pylori","volume":"106","author":"Jain","year":"2014","journal-title":"Curr. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0465","first-page":"1421","article-title":"Use of carbomers to design mucoadhesive microspheres for an anti-H. pylori drug, clarithromycin","volume":"1","author":"Thorat","year":"2009","journal-title":"Int. J. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0470","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10611860902718649","article-title":"Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori","volume":"17","author":"Ramteke","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0475","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/bm900985h","article-title":"Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of H. pylori","volume":"11","author":"Chang","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0480","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.procbio.2010.10.012","article-title":"Effect of microencapsulated precipitants of Lactobacillus casei ATCC 393 on Helicobacter pylori eradication","volume":"46","author":"Ko","year":"2011","journal-title":"Process Biochem."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0485","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jps.22351","article-title":"Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin","volume":"100","author":"Moogooee","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0490","first-page":"24","article-title":"Clarithromycin mucoadhesive microspheres for anti-Helicobacter pylori therapy: formulation and in vitro evaluation","volume":"2","author":"Venkateswaramurthy","year":"2010","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0495","first-page":"143","article-title":"In vivo evaluation of amoxicillin trihydrate and clarithromycin-loaded mucoadhesive microspheres for H. pylori eradication","volume":"12","author":"Venkateswaramurthy","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0500","first-page":"104","article-title":"Formulation and in vitro evaluation of furazolidone mucoadhesive microspheres","volume":"2","author":"Venkateswaramurthy","year":"2010","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0505","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0973-8398.97125","article-title":"Design and evaluation of controlled release mucoadhesive microspheres of amoxicillin for anti Helicobacter pylori therapy","volume":"5","author":"Venkateswaramurthy","year":"2011","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0510","first-page":"227","article-title":"Formulation and evaluation of stomach specific amoxicillin loaded mucoadhesive microspheres","volume":"6","author":"Venkateswaramurthy","year":"2010","journal-title":"Iran. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0515","first-page":"993","article-title":"Controlled release mucoadhesive microspheres of clarithromycin for the treatment of Helicobacter pylori infection","volume":"4","author":"Venkateswaramurthy","year":"2012","journal-title":"Pharm. Lett."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0520","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2011.04.030","article-title":"Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery","volume":"413","author":"Liu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0525","first-page":"1","article-title":"Preparation and characterization of sodium alginate-carbopol-924P based mucoadhesive microbeads","volume":"3","author":"Pal","year":"2011","journal-title":"Pharm. Lett."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0530","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.procbio.2012.05.019","article-title":"Formulation and evaluation of water-in-oil amoxicillin-loaded nanoemulsions using for Helicobacter pylori eradication","volume":"47","author":"Lin","year":"2012","journal-title":"Process Biochem."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0535","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijbiomac.2012.04.018","article-title":"Novel composite blend microbeads of sodium alginate coated with chitosan for controlled release of amoxicillin","volume":"51","author":"Angadi","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0540","first-page":"07","article-title":"Formulation and evaluation pH stimuli sensitive multiparticulate delivery system of clarithromycin for the treatment of Helicobacter pylori","volume":"5","author":"Tripathi","year":"2013","journal-title":"Int. J. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0545","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2013.12.052","article-title":"A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation","volume":"463","author":"Hao","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0550","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.actbio.2010.08.028","article-title":"Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori","volume":"7","author":"Chang","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0555","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10856-012-4567-9","article-title":"Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics","volume":"23","author":"Zhu","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2014.06.020_bb0560","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/nnm.13.30","article-title":"Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract","volume":"9","author":"Pan-In","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0565","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2231-4040.126996","article-title":"Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: design, development and optimization","volume":"5","author":"Ali","year":"2014","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0570","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2006.06.045","article-title":"Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation","volume":"324","author":"Raffin","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0575","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-5378.1999.09046.x","article-title":"Oral immunization with Helicobacter pylori-loaded poly(d, l-lactide-co-glycolide) nanoparticles","volume":"4","author":"Kim","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0580","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3748\/wjg.v8.i6.1098","article-title":"PELA microspheres loaded H. pylori lysates and their mucosal immune response","volume":"8","author":"Ren","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0585","series-title":"2nd Portuguese Meeting in Bioengineering (ENBENG), Coimbra","article-title":"Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: in vivo evaluation","author":"Figueiredo","year":"2012"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0590","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1021\/la402695c","article-title":"Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery","volume":"29","author":"Thamphiwatana","year":"2013","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0595","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/1061186X.2013.784978","article-title":"Development and characterization of nanolipobeads-based dual drug delivery system for H. pylori targeting","volume":"21","author":"Jain","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070776","article-title":"The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles","volume":"8","author":"Chakraborti","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2014.06.020_bb0605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molstruc.2013.12.073","article-title":"Synthesis, physicochemical characterization, DFT calculation and biological activities of Fe(III) and Co(II)\u2013omeprazole complexes. Potential application in the Helicobacter pylori eradication","volume":"1061","author":"Russo","year":"2014","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0610","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.3390\/ijms13089923","article-title":"Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori","volume":"13","author":"Amin","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0615","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s10856-012-4716-1","article-title":"In vitro cytotoxicity of surface modified bismuth nanoparticles","volume":"23","author":"Luo","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0620","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1039\/b601764a","article-title":"Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate","author":"Chen","year":"2006","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0625","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.materresbull.2009.12.035","article-title":"Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties","volume":"45","author":"Chen","year":"2010","journal-title":"Mater. Res. Bull."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0630","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12010-013-0571-x","article-title":"The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori","volume":"172","author":"Nazari","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0635","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetpar.2011.05.028","article-title":"Nanomedicine: novel approaches in human and veterinary therapeutics","volume":"180","author":"Irache","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0640","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2006.09.014","article-title":"Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation","volume":"331","author":"Inoue","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0645","first-page":"131","article-title":"The relationship between antioxidant and anti-ulcer activities in Saudi honey samples harvested from various regions in different seasons","volume":"04","author":"Al-Jaber","year":"2013","journal-title":"Food Nutr. Sci."},{"key":"10.1016\/j.jconrel.2014.06.020_bb0650","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.taap.2011.11.010","article-title":"Nanotoxicology and in vitro studies: the need of the hour","volume":"258","author":"Arora","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914004192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914004192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T04:02:24Z","timestamp":1597982544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914004192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":130,"alternative-id":["S0168365914004192"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of Helicobacter pylori: Past, present and future","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}